News

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could ...